iShares U.S. Pharmaceuticals ETF (IHE)

143.63
Delayed Data
As of Sep 16
 -0.16 / -0.11%
Today’s Change
131.91
Today|||52-Week Range
170.26
+2.03%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

No recent news for iShares U.S. Pharmaceuticals ETF.

Performance

1 month+0.96% 3 years+0.01%
3 months-1.16% 5 years+2.11%
1 year-13.30% Since inception+9.73%
Data through 09/14/2019

Quote Details

Previous close$143.79
Open day’s range142.66 – 144.02
Net asset value (NAV)143.83 (09/13/2019)
Daily volume3,942
Average volume (3 months)13,975
Data as of 8:00pm ET, 09/16/2019

Peer Comparisonvs. Health ETFs

 IHECategory
Performance 5-yr return+2.11%+9.15%
Expense Gross exp ratio0.42%1.24%
Risk 5 year sharpe ratio0.120.46
Net assets$327.8M$3.0B
Average market cap$50.7B$36.1B
Average P/E22.824.1
Dividend / Share--0.26%

Competitors

FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...
IHI iShares U.S. Medical Devices ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson21.35%
PFE Pfizer19.45%
AGN Allergan6.16%
ZTS Zoetis Inc5.35%
MRK Merck4.87%
MYL Mylan NV4.77%
BMY Bristol-Myers Squibb4.76%
LLY Eli Lilly and Co4.62%
ELAN Elanco Animal Health Inc3.77%
CTLT Catalent Inc3.65%